{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:13:23Z","timestamp":1788437603769,"version":"build-2803163510"},"reference-count":49,"publisher":"American Chemical Society (ACS)","issue":"34","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004728","name":"VIT University","doi-asserted-by":"publisher","award":["SG20250035"],"award-info":[{"award-number":["SG20250035"]}],"id":[{"id":"10.13039\/501100004728","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Metal-based chemotherapy has remained a cornerstone of cancer treatment since the clinical introduction of cisplatin; however, systemic toxicity, dose-limiting nephrotoxicity, and acquired resistance continue to limit its therapeutic efficacy. These challenges have stimulated the development of non-platinum-metal-based agents, particularly ruthenium(II\/III) and iridium(III) complexes, which offer tunable coordination environments, redox adaptability, and diverse mechanisms of action. Among the ligand systems investigated, Schiff bases have emerged as versatile scaffolds capable of modulating complex stability, lipophilicity, and target selectivity. This Review critically examines recent advances (2023\u20132025) in Schiff base ruthenium and iridium complexes, with emphasis on their structure\u2013activity relationships and anticancer mechanisms. Recent Schiff base Ru(II\/III) complexes have demonstrated promising DNA-binding, redox-modulating, and apoptosis-inducing properties, whereas several Ir(III) complexes exhibit potent cytotoxicity, phosphorescence imaging capability, and phototherapeutic potential, supporting their development as theranostic agents. Mechanistic studies reveal multimodal activity involving DNA interactions, human serum albumin (HSA) binding, reactive oxygen species (ROS) modulation, mitochondrial dysfunction, and apoptosis induction. Emerging strategies, including NIR-activated phototherapy, nanocarrier-assisted delivery, and computational approaches such as molecular docking and density functional theory (DFT) calculations, are further highlighted as promising directions for the rational design of next-generation metal-based anticancer therapeutics.<\/jats:p>","DOI":"10.1021\/acsomega.6c04624","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T09:56:42Z","timestamp":1787306202000},"page":"50617-50625","source":"Crossref","is-referenced-by-count":0,"title":["Evolution of Metal-Based\nAnticancer Therapeutics:\nChemical Foundations, Platinum Drugs, and Emerging Schiff Base Ruthenium(II)\nand Iridium(III) Complexes"],"prefix":"10.1021","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2824-7012","authenticated-orcid":true,"given":"Bhumika","family":"Joshi","sequence":"first","affiliation":[{"name":"Vellore Institute of Technology (VIT) , , ,","place":["Vellore, India, 632014"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3637-0719","authenticated-orcid":true,"given":"Murugesh","family":"Shivashankar","sequence":"additional","affiliation":[{"name":"Vellore Institute of Technology (VIT) , , ,","place":["Vellore, India, 632014"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"2026090307193248700_cit1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.107337","article-title":"Coordination Chemistry-Based\nBioinspired and Biomimetic Systems for Biomedical Applications","volume":"113","author":"Khulood","year":"2025","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"8","key":"2026090307193248700_cit2","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1021\/acs.accounts.4c00031","article-title":"Supramolecular Coordination\nComplexes for Synergistic Cancer Therapy","volume":"57","author":"Li","year":"2024","journal-title":"Acc.\nChem. Res."},{"issue":"11","key":"2026090307193248700_cit3","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.3390\/biom15111568","article-title":"Heteroaromatic\nHybrid Benzimidazole\/Oxadiazole (BZ\/OZ) Ligand and Its Sm(III) Complex:\nStudy of Their Antibacterial Activity, Toxicological Prediction and\nInteraction with Different Model Membranes","volume":"15","author":"Arago\u0301n-Muriel","year":"2025","journal-title":"Biomolecules"},{"issue":"1","key":"2026090307193248700_cit4","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/biom16010154","article-title":"Evaluating the Antiproliferative\nEffects of Tri(2-Furyl)- and Triphenylphosphine-Gold(I) Pyridyl- and\nPyrimidine-Thiolate Complexes","volume":"16","author":"Wilhelm","year":"2026","journal-title":"Biomolecules"},{"key":"2026090307193248700_cit5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1542560","article-title":"The Outcast\nof Medicine: Metals in Medicine--from Traditional Mineral Medicine\nto Metallodrugs","volume":"16","author":"Bai","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"1","key":"2026090307193248700_cit6","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-023-00996-1","article-title":"Study of\nNovel Bidentate Heterocyclic Amine-Based Metal Complexes and Their\nBiological Activities: Cytotoxicity and Antimicrobial Activity Evaluation","volume":"17","author":"Fahmy","year":"2023","journal-title":"BMC Chem."},{"issue":"9","key":"2026090307193248700_cit7","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin Nephrotoxicity: Mechanisms\nand Renoprotective Strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int."},{"issue":"1","key":"2026090307193248700_cit8","doi-asserted-by":"publisher","DOI":"10.1038\/s41427-023-00473-0","article-title":"Tumor Microenvironment-Responsive\nMetal Nanotherapeutics for Breast\nCancer Chemo-\/Immunotherapy","volume":"15","author":"Liu","year":"2023","journal-title":"NPG Asia Mater."},{"key":"2026090307193248700_cit9","doi-asserted-by":"publisher","first-page":"5375","DOI":"10.2147\/DDDT.S275007","article-title":"Ruthenium\nComplexes as Anticancer\nAgents: A Brief History and Perspectives","volume":"14","author":"Lee","year":"2020","journal-title":"Drug\nDes. Dev. Ther."},{"key":"2026090307193248700_cit10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2025.216477","article-title":"Bridging the Gap between Theory and\nTreatment: Transition Metal Complexes as Successful Candidates in\nMedicine","volume":"531","author":"Abdolmaleki","year":"2025","journal-title":"Coord. Chem. Rev."},{"issue":"2","key":"2026090307193248700_cit11","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1021\/acscentsci.3c01340","article-title":"Metals in\nCancer Research: Beyond Platinum Metallodrugs","volume":"10","author":"Casini","year":"2024","journal-title":"ACS Cent. Sci."},{"issue":"44","key":"2026090307193248700_cit12","doi-asserted-by":"publisher","first-page":"16339","DOI":"10.1039\/D2NR02994D","article-title":"Ruthenium-Based\nAntitumor\nDrugs and Delivery Systems from Monotherapy to Combination Therapy","volume":"14","author":"Lu","year":"2022","journal-title":"Nanoscale"},{"key":"2026090307193248700_cit13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jorganchem.2025.123814","article-title":"Iridium Complexes\nin Cancer Treatment: A Promising Complement to Cis-Platin \u2013\nA Mini Review","volume":"1040","author":"Mandal","year":"2025","journal-title":"J. Organomet. Chem."},{"key":"2026090307193248700_cit14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2021.214016","article-title":"Recent Advances in\nRuthenium(II) and Iridium(III) Complexes Containing Nanosystems for\nCancer Treatment and Bioimaging","volume":"443","author":"Shen","year":"2021","journal-title":"Coord. Chem.\nRev."},{"key":"2026090307193248700_cit15","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116211","article-title":"A Review on\nMetal Complexes and Its\nAnti-Cancer Activities: Recent Updates from in Vivo Studies","volume":"171","author":"Adhikari","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"30","key":"2026090307193248700_cit16","doi-asserted-by":"publisher","first-page":"9934","DOI":"10.1039\/C8DT01858H","article-title":"Anticancer\nActivity\nof Complexes of the Third Row Transition Metals, Rhenium, Osmium,\nand Iridium","volume":"47","author":"Konkankit","year":"2018","journal-title":"Dalton Trans."},{"issue":"10","key":"2026090307193248700_cit17","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.3390\/molecules24101995","article-title":"NAMI-A and KP1019\/1339,\nTwo Iconic Ruthenium Anticancer\nDrug Candidates Face-to-Face: A Case Story in Medicinal Inorganic\nChemistry","volume":"24","author":"Alessio","year":"2019","journal-title":"Molecules"},{"issue":"4","key":"2026090307193248700_cit18","first-page":"97","article-title":"Cisplatin-Based\nChemotherapy of Human\nCancers","volume":"11","author":"Brown","year":"2019","journal-title":"J. Cancer Sci. Ther."},{"issue":"1","key":"2026090307193248700_cit19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00280-010-1293-1","article-title":"Ruthenium-Based Chemotherapeutics:\nAre They Ready for Prime Time?","volume":"66","author":"Antonarakis","year":"2010","journal-title":"Cancer Chemother.\nPharmacol."},{"issue":"21","key":"2026090307193248700_cit20","doi-asserted-by":"publisher","first-page":"13552","DOI":"10.1021\/acs.inorgchem.8b02161","article-title":"Half-Sandwich Iridium and Ruthenium\nComplexes: Effective Tracking in Cells and Anticancer Studies","volume":"57","author":"Li","year":"2018","journal-title":"Inorg. Chem."},{"issue":"38","key":"2026090307193248700_cit21","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.3c03234","article-title":"Cyclometalated Ir(III)\nComplexes as Lysosome-Targeted Photodynamic Anticancer Agents","volume":"8","author":"Zhu","year":"2023","journal-title":"ACS Omega"},{"issue":"28","key":"2026090307193248700_cit22","doi-asserted-by":"publisher","DOI":"10.1039\/D5RA03076E","article-title":"Anticancer\nEfficacy\nof Bis-Heteroleptic Iridium(Iii) Complexes with Difluoro-Substituted\nPhenylpyridine Ligands","volume":"15","author":"Behera","year":"2025","journal-title":"RSC Adv."},{"key":"2026090307193248700_cit23","doi-asserted-by":"publisher","DOI":"10.1016\/j.poly.2023.116485","article-title":"Recent Advancements in Coordination\nCompounds and Their Potential Clinical Application in the Management\nof Diseases: An up-to-Date Review","volume":"241","author":"Kumar Singh","year":"2023","journal-title":"Polyhedron"},{"key":"2026090307193248700_cit24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ccr.2018.01.010","article-title":"Cyclometalated\nIridium(III) Luminescent Complexes in Therapy and Phototherapy","volume":"360","author":"Zamora","year":"2018","journal-title":"Coord. Chem. Rev."},{"key":"2026090307193248700_cit25","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2147\/DDDT.S119488","article-title":"Metal Complexes\nin Cancer Therapy\n\u2013 an Update from Drug Design Perspective","volume":"Volume11","author":"Ndagi","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"2026090307193248700_cit26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2024.215663","article-title":"Recent Developments in the Biological Activities of 3d-Metal Complexes\nwith Salicylaldehyde-Based N, O-Donor Schiff Base Ligands","volume":"505","author":"Kumar","year":"2024","journal-title":"Coord. Chem. Rev."},{"issue":"46","key":"2026090307193248700_cit27","doi-asserted-by":"publisher","first-page":"43408","DOI":"10.1021\/acsomega.3c04867","article-title":"Recent Advancement in the Synthesis\nof Ir-Based Complexes","volume":"8","author":"Joshi","year":"2023","journal-title":"ACS Omega"},{"issue":"38","key":"2026090307193248700_cit28","doi-asserted-by":"publisher","first-page":"16633","DOI":"10.1039\/C5DT02661J","article-title":"The Exceptionally\nRich Coordination Chemistry Generated by Schiff-Base Ligands Derived\nfrom o-Vanillin","volume":"44","author":"Andruh","year":"2015","journal-title":"Dalton Trans."},{"issue":"16","key":"2026090307193248700_cit29","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.3390\/ma13163491","article-title":"Ruthenium(II)\nand Iridium(III) Complexes as Tested\nMaterials for New Anticancer Agents","volume":"13","author":"Masternak","year":"2020","journal-title":"Materials"},{"issue":"7","key":"2026090307193248700_cit30","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3390\/cancers13071572","article-title":"Mechanisms\nof Cisplatin-Induced Acute Kidney Injury:\nPathological Mechanisms, Pharmacological Interventions, and Genetic\nMitigations","volume":"13","author":"McSweeney","year":"2021","journal-title":"Cancers"},{"issue":"11","key":"2026090307193248700_cit31","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of Cisplatin\nNephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins"},{"issue":"10","key":"2026090307193248700_cit32","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.biochi.2009.03.017","article-title":"Unusual DNA Binding\nModes for Metal Anticancer Complexes","volume":"91","author":"Pizarro","year":"2009","journal-title":"Biochimie"},{"issue":"7","key":"2026090307193248700_cit33","doi-asserted-by":"publisher","first-page":"4705","DOI":"10.1039\/C7SC01070B","article-title":"Photochemically\nActive DNA-Intercalating\nRuthenium and Related Complexes \u2013 Insights by Combining Crystallography\nand Transient Spectroscopy","volume":"8","author":"Cardin","year":"2017","journal-title":"Chem. Sci."},{"key":"2026090307193248700_cit34","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.saa.2018.08.009","article-title":"Comment on the Frequently Used Method\nof the Metal Complex-DNA Binding Constant Determination from UV\u2013Vis\nData","volume":"206","author":"Gamov","year":"2019","journal-title":"Spectrochim. Acta, Part A"},{"key":"2026090307193248700_cit35","doi-asserted-by":"publisher","first-page":"111146","DOI":"10.1016\/j.dyepig.2023.111146","article-title":"Antitumor Activity\nof Iridium\/Ruthenium\nComplexes Containing Nitro -Substituted Quinoline Ligands in Vivo\nand in Vitro","volume":"213","author":"He","year":"2023","journal-title":"Dyes Pigm."},{"issue":"8","key":"2026090307193248700_cit36","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.70204","article-title":"Synthesis\nand Biological Evaluation of \u03c0-Conjugated Ir(III) Complexes:\nCytotoxic Potential, DNA\/HSA Binding, Thermodynamics, and Antioxidant\nActivity","volume":"86","author":"Joshi","year":"2025","journal-title":"Drug Dev. Res."},{"issue":"6","key":"2026090307193248700_cit37","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1039\/b107656f","article-title":"Synthesis\nand DNA Binding Properties of Bioorganometallic\n(\u03975-Pentamethylcyclopentadienyl)Iridium(III) Complexes of the\nType [(\u03b75-pentamethylcyclopentadienyl)iridium(iii)\ncomplexes of the type [(\u03b75-C5Me5)Ir(Aa)(dppz)]n+ (dppz = dipyrido[3,2-a:2\u2032,3\u2032-c]phenazine, n = 1\u20133), with S-Coordinated Amino Acids (Aa) or\nPeptides","author":"Herebian","year":"2002","journal-title":"J. Chem. Soc., Dalton Trans."},{"issue":"9","key":"2026090307193248700_cit38","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1021\/acsptsci.2c00115","article-title":"Using Human\nSerum Albumin Binding Affinities as a Proactive Strategy\nto Affect the Pharmacodynamics and Pharmacokinetics of Preclinical\nDrug Candidates","volume":"5","author":"Fan","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"14","key":"2026090307193248700_cit39","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.3390\/ma15144957","article-title":"Thermodynamic\nand Kinetic Binding Behaviors of Human\nSerum Albumin to Silver Nanoparticles","volume":"15","author":"Tian","year":"2022","journal-title":"Materials"},{"issue":"7","key":"2026090307193248700_cit40","doi-asserted-by":"publisher","first-page":"11712","DOI":"10.1021\/acsomega.9b01022","article-title":"Design, Synthesis,\nDNA\/HSA Binding, and Cytotoxic Activity of Half-Sandwich Ru(II)-Arene\nComplexes Containing Triarylamine-Thiosemicarbazone Hybrids","volume":"4","author":"Muralisankar","year":"2019","journal-title":"ACS Omega"},{"issue":"3","key":"2026090307193248700_cit41","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jpha.2012.10.002","article-title":"Fluorescence\nSpectroscopy of Osthole Binding to Human Serum Albumin","volume":"3","author":"Yang","year":"2013","journal-title":"J. Pharm. Anal."},{"key":"2026090307193248700_cit42","doi-asserted-by":"publisher","first-page":"112792","DOI":"10.1016\/j.jinorgbio.2024.112792","article-title":"Effects of Structurally\nVaried\nFluorescent Half-Sandwich Iridium(III) Schiff Base Complexes on A549\nCell Line","volume":"263","author":"Liu","year":"2025","journal-title":"J. Inorg. Biochem."},{"issue":"P1","key":"2026090307193248700_cit43","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ccr.2015.06.014","article-title":"The Development\nof RAPTA Compounds for the Treatment of Tumors","volume":"306","author":"Murray","year":"2016","journal-title":"Coord. Chem. Rev."},{"issue":"14","key":"2026090307193248700_cit44","doi-asserted-by":"publisher","first-page":"5805","DOI":"10.1021\/acs.jmedchem.7b01689","article-title":"Ru(II)\nCompounds:\nNext-Generation Anticancer Metallotherapeutics?","volume":"61","author":"Thota","year":"2018","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026090307193248700_cit45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-03147-9","article-title":"Structural and Biomedical Investigations\nof Novel Ruthenium Schiff Base Complexes","volume":"15","author":"Ramadan","year":"2025","journal-title":"Sci.\nRep."},{"issue":"4","key":"2026090307193248700_cit46","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3390\/molecules30040801","article-title":"Cytotoxic Organometallic\nIridium(III) Complexes","volume":"30","author":"Kostova","year":"2025","journal-title":"Molecules"},{"issue":"14","key":"2026090307193248700_cit47","doi-asserted-by":"publisher","first-page":"7879","DOI":"10.3390\/ijms25147879","article-title":"Ruthenium(II) Complex-Based\nTetradentate Schiff Bases: Synthesis, Spectroscopic, Antioxidant,\nand Antibacterial Investigations","volume":"25","author":"Es-Sounni","year":"2024","journal-title":"Int. J.\nMol. Sci."},{"key":"2026090307193248700_cit48","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2020.129402","article-title":"Cobalt and Ruthenium Complexes with Pyrimidine Based\nSchiff Base: Synthesis, Characterization, Anticancer Activities and\nElectrochemotherapy Efficiency","volume":"1226","author":"Alk\u0131s\u0327","year":"2021","journal-title":"J. Mol. Struct."},{"issue":"22","key":"2026090307193248700_cit49","doi-asserted-by":"publisher","first-page":"7304","DOI":"10.1039\/D5QI00775E","article-title":"New Encapsulated\nBis-Cyclometalated Ir(III) Complexes with Very Potent Anticancer PDT\nActivity","volume":"12","author":"Bermejo-Casadesu\u0301s","year":"2025","journal-title":"Inorg. Chem. Front."}],"container-title":["ACS Omega"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsomega.6c04624","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/acsodf\/article-pdf\/11\/34\/50617\/66930908\/acsomega.6c04624.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/acsodf\/article-pdf\/11\/34\/50617\/66930908\/acsomega.6c04624.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:19:39Z","timestamp":1788434379000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/acsodf\/article\/11\/34\/50617\/5280514\/Evolution-of-Metal-Based-Anticancer-Therapeutics"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":49,"journal-issue":{"issue":"34","published-online":{"date-parts":[[2026,8,20]]},"published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1021\/acsomega.6c04624","relation":{},"ISSN":["2470-1343"],"issn-type":[{"value":"2470-1343","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]}}}